All In Biotech

Free tool

FAERS Monitor: Sarafem

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018936 or its brand name (Sarafem, Fluoxetine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

63,050

Serious

39,616

63% of reports

Hospitalization

17,341

Death reported

3,988

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective4,661
  • fatigue4,344
  • nausea4,301
  • headache3,758
  • depression3,706
  • anxiety3,422
  • pain3,103
  • dizziness2,925
  • diarrhoea2,863
  • off label use2,734
  • insomnia2,671
  • dyspnoea2,641
  • vomiting2,530
  • fall2,447
  • weight increased2,210

Reports by year received

View as table
YearReports
20041,705
20051,710
20061,680
20071,443
20081,409
20091,920
20102,252
20112,519
20123,268
20132,581
20142,868
20155,363
20164,442
20173,305
20183,296
20193,332
20202,801
20212,462
20223,084
20232,963
20243,226
20253,036
20262,383

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,991,109 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
depressionSignal3,7065.55.313,589
anxietySignal3,4224.03.97,862
insomniaSignal2,6713.43.24,459
weight increasedSignal2,2103.33.23,573
fallSignal2,4472.52.42,144
headacheSignal3,7582.01.91,940
dizziness2,9252.01.91,404
fatigue4,3441.91.81,802
nausea4,3011.81.81,633
vomiting2,5301.81.7913
pain3,1031.71.6892
dyspnoea2,6411.61.5541
diarrhoea2,8631.51.4460
drug ineffective4,6611.21.1136
off label use2,7341.01.05

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.